Multiple Myeloma Clinical Trial
Study of Hypotensive Hematopoietic Malignancy Patients’ USCOM Readings
Summary
The purpose of this study is to test how practical it is to use the Ultrasonic Cardiac Output Monitor (USCOM), an FDA-approved device, on oncology patients (specifically those with blood cancers). Additionally, the researchers will learn if the USCOM gives additional information about patients' conditions when their blood pressures drop and they are treated with intravenous fluids.
Eligibility Criteria
Inclusion Criteria:
-≥ 18 years of age
English speaker
Diagnosis of blood dyscrasia, hematopoietic malignancy, or condition that may requires HSCT
Exclusion Criteria:
Obstruction of the suprasternal notch that prevents placing the USCOM probe in the correct location
Tracheostomy or endotracheal tube that prevents placing USCOM probe in the correct location
Inability to lie flat, on left or right side, or with the head of bed at a 30 degree angle for the USCOM exam (ex. due to respiratory distress or physiologic reasons)
Impairment by a psychiatric, cognitive, or physiologic disorder that limits ability to understand explanation of study and give consent
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
St. Louis Missouri, 63110, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.